Navigation Links
Westaim announces 2008 third quarter results
Date:11/12/2008

hareholder value. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise. Accordingly, readers are advised not to place undue reliance on forward-looking statements, and should not rely on this information at any date other than the date of this news release. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

THE WESTAIM CORPORATION

Financial Highlights

(unaudited)

(thousands of dollars except per share data)

-------------------------------------------------------------------------

Three Months Ended Nine Months Ended

September 30 September 30

Consolidated Statements ------------------- -------------------

of Operations 2008 2007 2008 2007

-------------------------------------------------------------------------

Revenue $ 5,466 $ 7,839 $ 15,428 $ 20,656

Loss from continuing operations (1,851) (8,773) (511) (3,996)

Net loss (3,122) (17,138) (12,981) (31,226)

Net loss per common share

- basic and diluted

Continuing operations (0.02) (0.09) (0.01) (0.04)

Net loss (0.03) (0.18) (0.14) (0.33)

Weighted average number of common

shares outstanding (thousands) 94,215 94,098 94,205 94,047

-------------------------------------------------------------------------

Three Months Ended Nine Months Ended

September 30 September 30

------------------- -------------------

Segmented Informat
'/>"/>

SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
2. Westaim terminates reorganization agreement and cancels shareholders meeting
3. Westaim to deregister its common stock in the United States
4. Westaim announces sale of iFire Technology Ltd. assets
5. Westaim announces 2008 second quarter results
6. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
7. Westaim announces 2008 first quarter results
8. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
9. Westaim announces 2007 year-end results
10. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
11. Westaim reduces ABCP exposure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Doctor house calls now ava...an. , New York, NY (PRWEB...gement physician, will now offer routine house cal...ients will be able to request a house call by ca...il from davisbregman.com . The convenience of bei...
(Date:11/9/2009)... A new website providing su...lung cancer has been launched at TheFaceofLungCanc...and survivors while distilling important informati... (PRWEB) November 9, 2009 ... public square, and in recognition of November&rsq...
(Date:11/9/2009)... Omnetics Connector Corpora...A systems have been certified. , ...- Omnetics Connector Corporation, the leading manu...ed that their design, production and QA systems ha...& AS9100 Revision B, International Quality System ...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 HUYA Biosc...,s biopharmaceutical innovation, today announced a... and Pharmacy, Ocean University of China. The agre...t HUYA has established with China,s leading resear...lerate the global development and commercializatio...
(Date:11/9/2009)...A new study finds that women treated for breast ca...ey have dense breasts. Published in the December 1... of the American Cancer Society, the study,s resul... breasts may benefit from additional therapies fol...udies indicate that women with dense breast tissue...
Breaking Medicine News(10 mins):Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 2Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 3Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Breast density associated with increased risk of cancer recurrence 2
...l/ - Haemacure Corporation (TSX :,HAE), a Montreal...ng,high-value human plasma-derived protein product...ed $7.8 million through the exercise of amended,Se...strated their strong,support by exercising their w...
... for individuals with diabetes who prefer a no-co... Simplicity. -, MINNEAPOLIS, J...CARD(TM) X-METER Blood Glucose Monitoring System a...the FDA,for sale in the U.S., (Photo: http://www...
...editor of Circulation: Cardiovascular Imaging . ...e latest in a series of six new titles to be publi...he American Heart Association. The journals will ...ociate professor of medicine and radiology at Brig...
...e ALLTEL Pavilion at the VCU Stuart C.... June 16 As part of their ongoing,commitment to s... Shield in,Virginia and James Blake are pleased to...les team, Bob and,Mike Bryan. All four players are...
...y federal program, WOODLAND HILLS, Calif., June 1...Blue Shield Association has awarded its Best of,Bl... to eight other,affiliated Blue plans., The Blue ...ht Anthem FEP plans that received this designation...
...at detects and treats cancer cells that are resist...tion showed success in the laboratory and could ev...ording to researchers at SNM,s 55th Annual Meeting...them unresponsive to most current treatments. , "...
Other Medicine News:Health News:Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic 2Health News:Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic 3Health News:ARKRAY USA Nationally Launches GLUCOCARD(TM) X-METER Blood Glucose Monitoring System 2Health News:American Heart Association's 3rd new journal -- Circulation: Cardiovascular Imaging 2Health News:James Blake and Andy Roddick Team up With the Bryan Brothers for AnthemLIVE! 2008 2Health News:James Blake and Andy Roddick Team up With the Bryan Brothers for AnthemLIVE! 2008 3Health News:James Blake and Andy Roddick Team up With the Bryan Brothers for AnthemLIVE! 2008 4Health News:New therapy shows promise for fighting treatment-resistant cancer cells 2
(Date:11/6/2009)..., Nov. 6 NuVasive, Inc. ... on developing products for minimally disruptive s...the appointment of Michael J. Lambert as Executive...tive November 9, 2009. The Company also announced...,, "Michael will be an excellent complement to ...
(Date:11/6/2009)... Manitoba, Nov. 6 With his propose...has set his sights on cutting name-brand prescript... who fall into the "Part D" coverage gap, universa... about the potential cost-cutting and feel it,s a ... the most powerful lobbyists want a revised progra...
(Date:11/6/2009)...Nov. 6 Cyberonics, Inc. ...will report financial results for the second quart...g April 30, 2010 on Wednesday, November 18, 2009 a...nce call to discuss those results on Thursday, Nov... 2010 Second Quarter Results Conference Call Instr...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 1Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 3Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 4Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 5Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 6Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 7Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 8Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 9Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 10Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 11Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 12Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 13Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 14Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 15Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 16Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 17Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 18Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 19Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 20Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 21Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 22Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 23Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 24Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 25Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 26Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 27Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 28Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 29Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 30Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 31DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 1Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 2
...tors to Better Target Patients for ALIMTA(R), (pem...ll Cell Lung Cancer, BARCELONA, Spain, Sept. 25 ...mall cell lung cancer (NSCLC) that,are classified ...ically,significant higher survival when treated in...d for injection) when compared to,histologically-s...
... (DSMB) Authorizes Enrollment of Cervical ...el, HOPKINTON, Mass., Sept. 24 Alseres,Pharmaceu...ndependent Data,Safety Monitoring Board (DSMB) has...ase I/IIa clinical trial in acute spinal cord inju... treated with a 9 mg dose of,Cethrin(R). This reco...
Other Medicine Technology:Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 2Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 3Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 4Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 5Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 6Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 7Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 8Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 2Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 3Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 4Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 5
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: